ADHD Treatment Has Evolved — And So Should Your Options
Newer Medications Like Qelbree, Azstarys, Daytrana, and Jornay PM Offer More Flexibility, and Better Lifestyle Fit
At Different Mental Health, we believe ADHD care should be as dynamic as the people we serve. For years, stimulant medications have been the cornerstone of treatment — but many come with limitations, from short durations and emotional crashes to insomnia, dependency concerns, and even prescription shortages.
Fortunately, today’s ADHD treatments are more advanced, accessible, and customizable than ever before.
Whether you’re navigating school, parenting, work demands, or simply seeking more balanced focus and energy, new options like Qelbree, Azstarys, Daytrana, and Jornay PM are changing the game.
Qelbree: A Non-Stimulant That Works Quickly and Stays Consistent
Qelbree (viloxazine hydrochloride) is a modern non-stimulant treatment for ADHD that’s FDA-approved for both children and adults. Unlike older non-stimulants, Qelbree offers faster titration, with some individuals noticing improvements in as little as one to two weeks.
Qelbree is not a controlled substance, which makes it easier to prescribe, refill, and access — especially during times of stimulant shortages. It is typically stocked consistently at pharmacies and can be filled in 30- or 90-day supplies, including through mail order.
It also offers a generous copay savings program for those with commercial insurance and a patient assistance program that may allow qualifying uninsured individuals to receive the medication at no cost.
Because it provides 24-hour symptom coverage without a harsh “crash,” Qelbree can support not just focus and productivity, but also mood regulation, sleep, and anxiety — areas where traditional stimulants often fall short.
Azstarys: Long-Lasting Stimulant Relief Without the Afternoon Crash
Azstarys is a next-generation stimulant that combines a fast-acting and long-acting component, providing up to 13 hours of symptom coverage. This extended duration makes it ideal for people with long days — whether that’s work, school, or after-hours responsibilities.
Its smoother onset and offset help reduce the sharp peaks and emotional crashes that can come with older stimulants. Many patients report fewer mood swings, more consistent focus, and a reduced need for mid-day dosing.
Daytrana: A Stimulant Patch You Can Control
Daytrana is the only FDA-approved ADHD patch and offers a transdermal delivery of methylphenidate. Because it’s applied to the skin and absorbed gradually, it allows users to control when the medication starts and how long it lasts. Simply removing the patch starts the medication’s offset, which can help reduce insomnia or late-day overstimulation.
It’s a helpful option for college students, shift workers, and families looking for flexible dosing that adjusts to the demands of daily life.
Jornay PM: A Stimulant That Starts Working Before You Wake Up
Jornay PM is a unique stimulant designed to be taken at night, with a delayed onset that activates in the early morning. For those who struggle with getting started in the morning — hitting snooze, aimless scrolling, or lack of motivation — this formulation can help reduce that friction.
By providing symptom control upon waking, it’s a great option for busy parents, professionals with early commutes, or students with early classes. Jornay PM supports smoother mornings and helps people be productive from the moment they get out of bed.
Why Immediate-Release Stimulants Aren’t the First Choice
Immediate-release (IR) stimulants like Adderall IR or Ritalin IR remain widely prescribed, but they come with known drawbacks. IR stimulants are not FDA-approved for once-daily ADHD treatment and typically require multiple doses to maintain coverage.
This can lead to variable symptom control, emotional crashes, and a greater risk of misuse or dependence — particularly in adolescents and young adults. These medications also tend to have a higher potential for diversion when compared to longer-acting options.
For these reasons, many clinicians now prefer extended-release or alternative treatments that offer smoother, safer, and more consistent results.
A Balanced Approach: Medications Help — But They’re Not Risk-Free
While these newer medications offer real advantages in flexibility, duration, and tolerability, all medications carry potential risks and side effects. Some people may experience decreased appetite, difficulty sleeping, increased anxiety, elevated blood pressure, or mood changes. Others may find certain medications are less effective or come with unwanted effects unique to their body.
That’s why we take a personalized, evidence-informed approach to ADHD treatment. Our team carefully reviews each individual’s medical history, lifestyle needs, and treatment goals before recommending a plan. And we always discuss the risks, benefits, and alternatives so that you feel empowered in your care.
There’s a Better Way to Treat ADHD — And It Starts With a Conversation
Gone are the days of one-size-fits-all ADHD medications that wear off too soon, interfere with sleep, or leave you feeling worse after they fade. Whether you’re exploring non-stimulants like Qelbree, long-acting stimulants like Azstarys and Jornay PM, or customizable options like Daytrana, our team can help you find a treatment that fits your brain and your life.
At Different Mental Health, you’ll work with psychiatric providers who specialize in ADHD and understand the full range of treatment options — from medication to lifestyle supports. Together, we’ll create a plan that supports not just focus, but overall wellbeing.
Ready to explore your options?
Schedule your appointment online— where expert care meets real-life flexibility.
Frequently Asked Questions: Mental Health Treatment Evolution & Options
Mental health care has progressed from one-size-fits-all approaches to evidence-based, personalized plans that combine therapy, medication, objective assessment, digital tools, and remote access.
Modern options include multimodal care, telepsychiatry, trauma-informed therapy, personalized medication strategies, objective testing, and skill-based behavioral supports.
Traditional approaches can be limited by lack of personalization, inconsistent measurement, and restricted access, making it harder to match treatments with individual needs.
Yes. A data-driven evaluation and ongoing monitoring allow providers to tailor care — such as adjusting medications or therapy type — based on individual symptom patterns and functional goals.
Research supports that telepsychiatry is effective for many people, offering the same evidence-based therapies and medication management with improved accessibility and convenience.
Ask about evidence-based methods, how progress will be measured, clinician credentials, communication expectations, and how your preferences are integrated into care.
Objective tools provide measurable insight into symptoms and functioning, which helps clinicians make more precise treatment decisions and track progress over time.
Modern approaches can reassess your experience, using updated evaluations and treatment planning to find a personalized path forward rather than repeating old patterns.
